The Board of Directors of Maccura Biotechnology Co.Ltd has authorized a buyback plan on February 5, 2024.
Maccura Biotechnology Co.Ltd
Equities
300463
CNE1000020H3
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.35 CNY | -0.60% | -2.98% | -11.41% |
04-25 | Maccura Biotechnology Co.Ltd Proposes Final Cash Dividend for the Year 2023 | CI |
04-24 | Maccura Biotechnology Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.41% | 1.12B | |
-4.13% | 12.18B | |
+8.22% | 5.96B | |
+26.94% | 5.45B | |
-5.09% | 4.34B | |
-52.54% | 3.18B | |
+14.18% | 2.75B | |
+32.50% | 2.3B | |
-6.42% | 2.28B | |
-1.69% | 1.92B |
- Stock Market
- Equities
- 300463 Stock
- News Maccura Biotechnology Co.Ltd
- Maccura Biotechnology Co.Ltd authorizes a Buyback Plan.